You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

palbociclib

( PAL boe SYE klib )
Funding:
Exceptional Access Program
  • palbociclib TABLETS - For the treatment of post-menopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative unresectable locally advanced breast cancer or metastatic breast cancer, according to clinical criteria
Other Name(s): Ibrance™
Appearance: Tablet or capsule in various strengths and colours

Patient Info Sheet

Nov 2020

What it is used for

  • For treating certain types of hormone sensitive breast cancer that has spread to other parts of the body. Palbociclib is given together with another medication.


You might also be interested in